Flputnam Investment Management Co. Has $36.21 Million Stock Position in McKesson Corporation $MCK

Posted by on May 27th, 2026

Flputnam Investment Management Co. increased its stake in McKesson Corporation (NYSE:MCK – Free Report) by 4.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,139 shares of the company’s stock after acquiring an additional 2,069 shares during the quarter. Flputnam Investment Management Co.’s holdings in McKesson were worth $36,207,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Swedbank AB increased its holdings in McKesson by 42.2% in the fourth quarter. Swedbank AB now owns 886,283 shares of the company’s stock worth $727,009,000 after purchasing an additional 263,189 shares in the last quarter. SurgoCap Partners LP increased its holdings in McKesson by 68.7% in the third quarter. SurgoCap Partners LP now owns 452,261 shares of the company’s stock worth $349,390,000 after purchasing an additional 184,106 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its holdings in McKesson by 73.7% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 432,578 shares of the company’s stock worth $354,839,000 after purchasing an additional 183,590 shares in the last quarter. Danica Pension Livsforsikringsaktieselskab bought a new stake in McKesson in the third quarter worth approximately $135,352,000. Finally, Danske Bank A S bought a new stake in McKesson in the third quarter worth approximately $127,487,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In related news, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MCK. Wall Street Zen upgraded McKesson from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a report on Thursday, January 29th. Wells Fargo & Company decreased their price objective on McKesson from $925.00 to $812.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Evercore restated an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Finally, JPMorgan Chase & Co. decreased their price objective on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, McKesson has a consensus rating of “Moderate Buy” and an average target price of $968.87.

View Our Latest Research Report on MCK

McKesson Stock Down 1.3%

NYSE MCK opened at $756.11 on Wednesday. The company has a market cap of $90.89 billion, a price-to-earnings ratio of 19.65, a P/E/G ratio of 1.14 and a beta of 0.35. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The business has a 50 day moving average price of $830.95 and a 200-day moving average price of $854.59.

McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $11.69 EPS for the quarter, beating the consensus estimate of $11.56 by $0.13. The firm had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The company’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, equities research analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, June 1st. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is 8.53%.

McKesson Profile

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Featured Articles

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.